Firstsource Solutions Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/abnqxnd511zyl5rwypl2zyy9.pdf

Key Takeaways


Growth & Demand Environment

Idnani: "These are visible signs of the success of our initiatives to broad-base our revenues and build multiple growth engines."

Deal Wins & Pipeline

Three large deals signed in Q3, the third consecutive quarter of at least three wins. The pipeline exiting Q3 was among the highest ever, and management expressed confidence in sustaining the accelerated win momentum.

DealDetails
Top-10 NA healthcare payerExisting customer; selected to process their entire claims operations, a transformative scope expansion.
Top-3 NA consumer tech (GenAI)Firstsource selected to develop and evaluate content across multiple domains, validating and optimizing the client's GenAI model.
Large UK utility (expansion)Existing client; expanded scope across customer support and collections.
Australia healthcare insurerWon from one of the largest healthcare insurers in Australia, building on the beachhead created by the earlier telco win.
Idnani: "I believe that the strength of our deal wins and pipelines reflects our success in leveraging our deep industry and functional expertise, our partnerships in the technology ecosystem, and our ability to proactively bring automation and AI into the mix that is resonating well with our clients."

AI & Technology Strategy

Idnani: "What we are seeing today is that a human who leverages AI for their day-to-day work will replace a human who doesn't use AI."

Vertical & Segment Performance

Vertical / SegmentTrendCommentary
Healthcare▲ Strong YoY, flat QoQGrew 31% YoY; QoQ pause from payer slowdown ahead of open enrollment and elections; deal conversations resumed, Q4 closures expected.
BFS▲ SteadyAdded 7 new logos; collections platform delivering results; US consumer resilient despite delinquency uptick; mortgage refi volumes remain structurally suppressed with 80% of fixed-rate loans still at 5% or below.
Consumer Tech (AI services)▲ EmergingFourth top-five consumer tech logo added for AI services; GenAI model validation and optimization work is a new, fast-growing sub-segment.
Retail & Utilities▲ Pipeline-drivenHealthy deal pipeline expected to translate into broad-based growth in coming quarters; Ascensos jump-started retail presence.
Australia▲ Early rampMulti-tower telco deal in execution; healthcare insurer win in Q3; strong pipeline.
Europe▲ Surge~22% QoQ growth; carve-out conversations building pipeline; UK cost-pressure driving offshore/nearshore interest.
Idnani: "If you look at the Fannie Mae data, about 80% of the outstanding fixed rate mortgage loans are still at 5% or less from an interest rate standpoint. So, it's very clear that refi volumes are unlikely to come back very quickly, and anybody else who is selling you otherwise is probably smoking something else."

Margins & Investment Cycle


Competitive Positioning

Idnani: "At our size and scale, what it allows us to do is to be the challenger to incumbents, and the combination of deep domain and technology contextualized to the domain, I think is allowing us to take, share, and win against the larger players."

Guidance & Commitments

CommitmentSpecificsTimeline
FY25 revenue growth21.8%–22.3% constant currencyFY25 full year
FY25 EBIT margin11%–11.5% normalized band (excl. one-time acquisition charges)FY25 full year
Annual margin expansion50–75 bps per yearStarting FY26, over the medium term
DSO normalizationDSO to revert from 67 days; full-year OCF-to-EBITDA to normalizeQ4 FY25
Healthcare deal closuresSeveral closures expectedQ4 FY25
FY26 growth commentaryNo specifics yet; color to be provided with Q4 resultsQ4 FY25 earnings

Key Metrics

MetricQ3 FY25
Revenue₹2,102.4 cr, 32% YoY and 8.4% QoQ in USD terms
Constant currency revenue growth7.6% QoQ, 28% YoY; fifth straight quarter of over 3% QoQ CC growth
EBIT margin11.1%, broadly stable QoQ and YoY
Operating profit₹233.3 cr, up 37% YoY
Net profit₹160.3 cr, 16% QoQ and 25% YoY growth
Diluted EPS₹2.27
Tax rate20% for the quarter and nine months
FY25 constant currency revenue growth guidance21.8% to 22.3%
FY25 normalized EBIT margin guidance11% to 11.5% band, excluding one-time acquisition-related charges
Large deal wins3 in Q3, third consecutive quarter with at least three large deal wins
New logos added13, including 5 strategic logos (potential of at least US$5 million annual revenue)
Total headcount34,144, net addition of 1,246 in Q3
Trailing 12-month attrition31.4%, up from 30.6% in Q2
BFS vertical constant currency growth1.6% QoQ, 8% YoY; 7 new logos added
Healthcare vertical constant currency growthFlat QoQ, 31% YoY; 5 new logos added
CMT vertical constant currency growth3% QoQ, 14% YoY; 1 new logo added
Diverse portfolio constant currency growth80% QoQ, 193% YoY, including full-quarter impact of Ascensos acquisition
North America constant currency growth1.3% QoQ, 28% YoY
Europe constant currency growth~22% QoQ, 28% YoY
Onshore revenue share60%, down from ~74% in Q2 of last year; offshore and nearshore at 40%
Top 5 client revenue concentration29.2%, down from 35.8% in Q3 last year
Top 10 client revenue concentration43.5%, down from 52% in Q3 last year
Reported DSO67 days, up from 65 days in Q2
FCF to PAT159% in Q3, 78% for 9MFY25
Cash balance including investments₹250 cr
Net debt₹1,020 cr at end of Q3
Interim dividend₹4 per share
Net one-time gain₹8.8 cr, including ₹65.1 cr contingent consideration writeback, ₹28.4 cr intangible useful life charge, ₹13 cr potential credit loss, ₹15 cr special bonus provision
Women in workforce46%
GenAI and digital transformation learning hours~150,000 completed
ESG score81 by S&P Global, top 99th percentile of DJSI 2024
AccunAI acquisition consideration₹8 cr, 100% acquisition